Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Clinical trial NCT04022005 · COMPLETED

Trial details

NCT number: NCT04022005
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2019-06-19
Primary completion: 2022-11-16
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.